Ontology highlight
ABSTRACT:
PROVIDER: PRJNA984473 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR24948132_1.fastq.gz | Fastqsanger.gz | |||
| SRR24948132_2.fastq.gz | Fastqsanger.gz | |||
| SRR24948133_1.fastq.gz | Fastqsanger.gz | |||
| SRR24948133_2.fastq.gz | Fastqsanger.gz | |||
| SRR24948134_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 28 |
Similar Datasets
Project description:Acne is a common skin disease, closely involving bacterial infection, impaired lipid metabolism and host inflammatory response. Although microneedles (MNs) can deliver bacteriostats for acne treatment, the limited regulation of inflammatory microenvironment and lipid metabolism hinders the therapeutic effect on severe acne. Herein, we develop antimicrobial and anti-inflammatory peptides-laden MN (HMC-PEP MN) with a proteoglycan-mimetic peptide-grafted comb polymer as MN matrix, which effectively treats acne via regulation of both inflammatory microenvironment and lipid metabolism. Specifically, HMC-PEP MN inhibits the expression of pro-inflammatory factors by decreasing TREM2/M2 macrophage ratio in rabbit ear acne model. Integrative analyses of transcriptomic and metabolomic reveal that HMC-PEP MN effectively reduces sebaceous secretion, pro-inflammatory signal transduction, sustained proliferation and differentiation of keratinocytes via inhibition of the IGF1/IGF1R/PI3K/AKT/mTOR signaling pathway. The improved lipid metabolism of sebaceous glands is potential for inhibition of acne recurrence, which provides broad clinical application prospect.
2026-03-03 | GSE290953 | GEO
Project description:Sand biofilter for Mn removal Raw sequence reads
| PRJNA548793 | ENA
Project description:Checkpoint blockade targeting PD-L1 has transformed cancer immunotherapy but remains constrained by systemic immune-related toxicity and limited efficacy in poorly infiltrated tumors. Here, we report a manganese-enhanced ribozyme nanoplatform (PS473@NKMOF-101-[Mn]) that enables precise PD-L1 gene silencing and innate immune activation. PS473 is a rationally engineered variant of the natural Pistol ribozyme that exhibits high catalytic efficiency at GU-rich motifs, which is further potentiated by the use of Mn²⁺ as a cofactor. To overcome extracellular instability and ensure intracellular delivery, PS473 was encapsulated within a pH-responsive, Mn-doped metal–organic framework (NKMOF-101-[Mn]), which confers ribozyme protection and sustained Mn²⁺ release in the acidic tumor microenvironment. In vitro, PS473@NKMOF-101-[Mn] suppressed PD-L1 expression and macrophage activation. In vivo, the nanoplatform achieved over 90% tumor inhibition in a B16F10 melanoma model and enhanced CD8⁺ T-cell infiltration without systemic toxicity. Transcriptomic profiling further revealed the upregulation of type I interferon signaling and cGAS–STING pathway activation, indicating a synergistic mechanism combining gene knockdown and immunostimulation. This work presents a catalytically robust and immunologically active ribozyme-based nanotherapeutic, offering a promising strategy for targeted gene silencing and tumor immune reprogramming.
2026-01-01 | GSE302201 | GEO
Project description:Meningiomas are mostly benign brain tumors, with a potential for becoming atypical or malignant. Based on comprehensive genomic, transcriptomic and epigenomic analyses of meningiomas, we compared benign tumors to atypical ones. We show that the vast majority of primary (de novo) atypical meningiomas display loss of NF2, which co-occurs either with genomic instability or recurrent mutations in SMARCB1. These tumors harbor increased H3K27me3 repressive signal and a hypermethylated phenotype, mainly occupying the polycomb repressive complex 2 (PRC2) binding sites in human embryonic stem cells (hESCs), thereby phenocopying a more primitive cellular state. Consistent with this observation, and based on differential gene expression analysis as well as correlation of mRNA:miRNA regulatory networks, atypical meningiomas exhibit up-regulation of EZH2, the catalytic subunit of the PRC2 complex, well as the E2F2 and FOXM1 transcriptional networks that promote proliferation through activation of the cell cycle pathways. In addition, based on H3K27ac ChIP-seq analysis, we show atypical tumors to display an activated super-enhancer near the meningeal identity transcription factor ZIC1, leading to its transcriptional upregulation. The H3k27ac ChIP-seq data for 15 benign meningiomas and 2 dura samples listed below were created by Dr. Justin Cotney in Dr. James Noonan’s lab at Yale and previously published in a paper by our group with Drs. Cotney and Noonan as co-authors (Clark et al. Science, 2013). Sample IDs: MN-297, MN-288, MN-292, MN-163, MN-1037, MN-105, MN-201, MN-249, MN-191, MN-1066, MN-169, MN-291, MN-24, MN-79, MN-1044, CONTROL1, CONTROL2. In this study, we used these benign meningioma H3k27ac ChIP-seq data as controls and compared them to the newly created ChIP-seq data. Sample IDs: MN-54, MN-97 and MN-171. This GEO entry contains ChIP-seq results for both data sets.
2016-12-20 | GSE91372 | GEO
Project description:The most common genetic mutation found in familial and sporadic amyotrophic lateral sclerosis (ALS), as well as fronto-temporal dementia (FTD), is a repeat expansion in the C9orf72 gene. C9orf72 is highly expressed in human myeloid cells, and although neuroinflammation and microglial pathology are widely found in ALS/FTD, the underlying mechanisms are poorly understood. Here, using human induced pluripotent stem cell-derived microglia-like cells (hiPSC-MG) harbouring C9orf72 mutation (mC9-MG) together with gene-corrected isogenic controls (isoC9-MG) and C9ORF72 knock-out hiPSC-MG (C9KO-MG), we show that reduced C9ORF72 protein is associated with impaired phagocytosis and an exaggerated inflammatory response upon stimulation with lipopolysaccharide, driven by sustained activation of NLRP3 inflammasome and NF-kB signalling. Analysis of the hiPSC-MG C9ORF72 interactome revealed an association of C9ORF72 with key regulators of autophagy, a process involved in the homeostatic regulation of the innate immune response. We found impaired initiation of autophagy in C9KO-MG and mC9-MG. Furthermore, through motor neuron-microglial (MN-MG) co-culture studies, we identified that autophagy deficit in mC9-MG led to increased vulnerability of C9 MNs to excitotoxic stimulus. Pharmacological activation of autophagy ameliorated the sustained activation of NLRP3 inflammasome and NF-B signalling, reversed the phagocytic deficit found in mC9-MG and also reduced MN death in MN-MG co-cultures. We validated these findings in blood-derived macrophages from people with C9orf72 mutation. Our results reveal an important role for C9ORF72 in regulating microglial immune homeostasis and identify dysregulation in human myeloid cells as a contributor to neurodegeneration in ALS/FTD
2023-03-02 | PXD032320 | Pride
Project description:Microbial Stratification and DOM Removal in Drinking Water Biofilters Implications for Enhanced Performance
| PRJEB71363 | ENA